NVNO: enVVeno Medical Forward P/E Multiple

Graphic logo of envveno.com (NVNO)

The forward P/E dynamics of enVVeno Medical (NVNO) reflect the impact of regulatory uncertainties and a narrow product range on the share price, with 0.00 serving as the current metric level. Experienced management is successfully optimizing R&D costs, thereby maintaining shareholder confidence. Meanwhile, VenoValve offers a unique treatment method for venous insufficiency, addressing the root cause of the pathology for millions of people.

envveno.com - NVNO Price to Expected Earnings Ratio (period 07/04/2022 - 11/17/2026)

enVVeno Medical Corp. (NVNO) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental valuation:NVNO enVVeno Corp
Brand item of envveno.com

High confidence among vascular surgeons in enVVeno Medical (NVNO) innovative bioprostheses lays the foundation for profit growth, which is reflected in the company's forward P/E ratio. This indicator compares the current market value of shares with expected earnings per share, allowing investors to determine the premium paid for technological potential and assess the long-term sustainability of the business model.

Competitors of enVVeno Medical

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|ENOV (Enovis Corp) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Inc. IART|ESTA - Projected Price to Earnings|Beta Bionics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED CORPORATION|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen Surgical) - Forward P/E Multiple|SI-BONE Corp (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Forward P/E Multiple bioventus.com (BVS)|Forward P/E Multiple KIDS (OrthoPediatrics Corp)|Forward P/E Multiple Treace Medical Concepts Inc TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight, Inc.) - Projected Price to Earnings|ClearPoint Neuro Inc. - Future Price to Earnings Multiple|STXS (Stereotaxis Corporation) - Forward P/E Multiple|Projected Price to Earnings Ratio Neuronetics Inc. STIM|Future Price to Earnings Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forward Price to Earnings Multiple|Anika Therapeutics Inc. - Projected Price to Earnings|Forward P/E Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - Forward P/E Multiple|Market Cap to Projected Earnings Vivani Medical VANI|Xtant Medical (XTNT) - Future Price to Earnings|Price to Expected Earnings Ratio NMTC (NeuroOne Medical Technologies Corp.)|Future Price to Earnings modular-medical.com|Projected Price to Earnings Ratio myomo.com MYO|Forward P/E Multiple COCH|VVOS - Projected Price to Earnings Ratio|Future Price to Earnings sintx.com SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|autonomix.com - Market Cap to Future Earnings Ratio|INVO Bioscience, Inc. (IVF) - Future Price to Earnings|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO